Ahmad-Mansour N, Loubet P, Pouget C, Dunyach-Remy C, Sotto A, Lavigne JP, et al. Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins (Basel). 2021;13(10):677.

CAS  Article  Google Scholar 

Aubais Aljelehawy QH, Hadi Alshaibah LH, Abbas Al-Khafaji ZK. Evaluation of virulence factors among Staphylococcus aureus strains isolated from patients with urinary tract infection in Al-Najaf Al-Ashraf teaching hospital. Cell Mol Biomed Rep. 2021;1(2):78–87.

Article  Google Scholar 

Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol. 2012;2:12.

Article  Google Scholar 

Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC. The role of the Panton-valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(1):43–54.

CAS  Article  Google Scholar 

Young BC, Earle SG, Soeng S, Sar P, Kumar V, Hor S, et al. Panton-valentine leucocidin is the key determinant of Staphylococcus aureus pyomyositis in a bacterial GWAS. Elife. 2019;8:e42486.

Article  Google Scholar 

Loffler B, Niemann S, Ehrhardt C, Horn D, Lanckohr C, Lina G, et al. Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. Expert Rev Anti-Infect Ther. 2013;11(10):1041–51.

Article  Google Scholar 

Spaan AN, Henry T, van Rooijen WJM, Perret M, Badiou C, Aerts PC, et al. The staphylococcal toxin Panton-valentine Leukocidin targets human C5a receptors. Cell Host Microbe. 2013;13(5):584–94.

CAS  Article  Google Scholar 

Tromp AT, Van Gent M, Abrial P, Martin A, Jansen JP, De Haas CJC, et al. Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-valentine leukocidin. Nat Microbiol. 2018;3(6):708–17.

CAS  Article  Google Scholar 

Breurec S, Fall C, Pouillot R, Boisier P, Brisse S, Diene-Sarr F, et al. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-valentine leukocidin genes. Clin Microbiol Infect. 2011;17(4):633–9.

CAS  Article  Google Scholar 

Becker K, Schaumburg F, Fegeler C, Friedrich AW, Kock R. Prevalence of multiresistant microorganisms PMMS. Staphylococcus aureus from the German general population is highly diverse. Int J Med Microbiol. 2017;307(1):21–7.

CAS  Article  Google Scholar 

Brown ML, O'Hara FP, Close NM, Mera RM, Miller LA, Suaya JA, et al. Prevalence and sequence variation of Panton-valentine Leukocidin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the United States. J Clin Microbiol. 2012;50(1):86–90.

Article  Google Scholar 

Tattevin P, Schwartz BS, Graber CJ, Volinski J, Bhukhen A, Bhukhen A, et al. Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2012;55(6):781–8.

Article  Google Scholar 

Schaumburg F, Alabi AS, Mombo-Ngoma G, Kaba H, Zoleko RM, Diop DA, et al. Transmission of Staphylococcus aureus between mothers and infants in an African setting. Clin Microbiol Infect. 2014;20(6):O390–6.

CAS  Article  Google Scholar 

Rasigade JP, Trouillet-Assant S, Breurec S, Antri K, Lina G, Bes M, et al. The levels of antibodies to Panton-valentine leukocidin (PVL) vary with PVL prevalence along a north-to-south gradient. Eur J Clin Microbiol Infect Dis. 2015;34(5):927–33.

CAS  Article  Google Scholar 

Diep BA, Le VT, Badiou C, Le HN, Pinheiro MG, Duong AH, et al. IVIG-mediated protection against necrotizing pneumonia caused by MRSA. Sci Transl Med. 2016;8(357):357ra124.

Article  Google Scholar 

Mairpady Shambat S, Chen P, Nguyen Hoang AT, Bergsten H, Vandenesch F, Siemens N, et al. Modelling staphylococcal pneumonia in a human 3D lung tissue model system delineates toxin-mediated pathology. Dis Model Mech. 2015;8(11):1413–25.

PubMed  PubMed Central  Google Scholar 

Olaniyi RO, Pancotto L, Grimaldi L, Bagnoli F. Deciphering the pathological role of staphylococcal alpha-toxin and Panton-valentine Leukocidin using a novel ex vivo human skin model. Front Immunol. 2018;9:951.

Article  Google Scholar 

Niemann S, Bertling A, Brodde MF, Fender AC, Van de Vyver H, Hussain M, et al. Panton-valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion products. Sci Rep. 2018;8(1):2185.

Article  Google Scholar 

Tanaka J, Hirayama F, Yanase S, Uno S, Nakae T, Kamizono A, et al. Effective concentration of intravenous immunoglobulin for neutralizing Panton-valentine leukocidin in human blood. J Infect Chemother. 2018;24(5):383–8.

CAS  Article  Google Scholar 

Meyer TC, Michalik S, Holtfreter S, Weiss S, Friedrich N, Volzke H, et al. A comprehensive view on the human antibody repertoire against Staphylococcus aureus antigens in the general population. Front Immunol. 2021;12:651619.

CAS  Article  Google Scholar 

Alabi A, Kazimoto T, Lebughe M, Vubil D, Phaku P, Mandomando I, et al. Management of superficial and deep-seated Staphylococcus aureus skin and soft tissue infections in sub-Saharan Africa: a post hoc analysis of the StaphNet cohort. Infection. 2018;46(3):395–404.

Article  Google Scholar 

Gillet Y, Tristan A, Rasigade JP, Saadatian-Elahi M, Bouchiat C, Bes M, et al. Prognostic factors of severe community-acquired staphylococcal pneumonia in France. Eur Respir J. 2021;58(5):2004445.

CAS  Article  Google Scholar 

Hermos CR, Yoong P, Pier GB. High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clin Infect Dis. 2010;51(10):1138–46.

Article  Google Scholar 

Diep BA, Le VT, Visram ZC, Rouha H, Stulik L, Dip EC, et al. Improved protection in a rabbit model of community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia upon neutralization of Leukocidins in addition to alpha-Hemolysin. Antimicrob Agents Chemother. 2016;60(10):6333–40.

Article  Google Scholar 

Tran VG, Venkatasubramaniam A, Adhikari RP, Krishnan S, Wang X, Le VTM, et al. Efficacy of active immunization with attenuated alpha-Hemolysin and Panton-valentine Leukocidin in a rabbit model of Staphylococcus aureus necrotizing pneumonia. J Infect Dis. 2020;221(2):267–75.

CAS  Article  Google Scholar 

Loffler B, Hussain M, Grundmeier M, Bruck M, Holzinger D, Varga G, et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 2010;6(1):e1000715.

Article  Google Scholar